Evidence map›Paper›PMID 35310360›Full record

ArticleBioactive materials2022

In-vivo evaluation of molybdenum as bioabsorbable stent candidate.

Malgorzata Sikora-Jasinska, Lea M Morath, Maria P Kwesiga, Margaret E Plank, Alexia L Nelson, Alexander A Oliver, Martin L Bocks, Roger J Guillory, Jeremy Goldman

Open access · goldAbstract read
In one paragraph

Article in Bioactive materials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Insights into the biological effects of molybdenum in an insect model (Frontiers in bioengineering and biotechnology · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Malgorzata Sikora-JasinskaDepartment of Biomedical Engineering, Michigan Technological University, USA.
Lea M MorathDepartment of Biomedical Engineering, Michigan Technological University, USA.
Maria P KwesigaDepartment of Biomedical Engineering, Michigan Technological University, USA.
Margaret E PlankDepartment of Biomedical Engineering, Michigan Technological University, USA.
Alexia L NelsonDepartment of Biomedical Engineering, Michigan Technological University, USA.
Alexander A OliverDepartment of Biomedical Engineering, Michigan Technological University, USA.
Martin L BocksCase Western Reserve University School of Medicine, UH Rainbow Babies & Children's Hospital, Cleveland, OH, USA.
Roger J GuilloryDepartment of Biomedical Engineering, Michigan Technological University, USA.
Jeremy GoldmanDepartment of Biomedical Engineering, Michigan Technological University, USA.
Michigan Technological University · USRainbow Babies & Children's Hospital · US

Funding

Corrosion Fatigue Resistant and Intimal Hyperplasia Suppressive Biometal for Bioabsorbable StentsR01HL144739 · NHLBI · MICHIGAN TECHNOLOGICAL UNIVERSITY · PI DRELICH, JAROSLAW W · 2019 to 2021
$1.1M
Inhibition of Neointimal Hyperplasia by Zinc-Based Biodegradable Arterial DevicesR15HL147299 · NHLBI · MICHIGAN TECHNOLOGICAL UNIVERSITY · PI GOLDMAN, JEREMY · 2019 to 2019
$611k
NHLBI NIH HHS R01 HL144739NHLBI NIH HHS R15 HL147299
6 · The paper itself

Abstract

Biodegradable stents have tremendous theoretical potential as an alternative to bare metal stents and drug-eluting stents for the treatment of obstructive coronary artery disease. Any bioresorbable or biodegradable scaffold material needs to possess optimal mechanical properties and uniform degradation behavior that avoids local and systemic toxicity. Recently, molybdenum (Mo) has been investigated as a potential novel biodegradable material for this purpose. With its proven moderate degradation rate and excellent mechanical properties, Mo may represent an ideal source material for clinical cardiac and vascular applications. The present study was performed to evaluate the mechanical performance of metallic Mo

Indexed as

BiocompatibilityBiodegradable stentDegradationMolybdenum

Identifiers

PMID35310360
PMCPMC8897701
OpenAlexW3214497968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.